-
2061por Fukuhara, Takasuke, Wada, Masami, Nakamura, Shota, Ono, Chikako, Shiokawa, Mai, Yamamoto, Satomi, Motomura, Takashi, Okamoto, Toru, Okuzaki, Daisuke, Yamamoto, Masahiro, Saito, Izumu, Wakita, Takaji, Koike, Kazuhiko, Matsuura, Yoshiharu“…Apolipoprotein B (ApoB) and ApoE have been shown to participate in the particle formation and the tissue tropism of hepatitis C virus (HCV), but their precise roles remain uncertain. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2062“…Interferon-alpha (IFNα) has been used to treat chronic hepatitis C virus (HCV) infection for over 20 years with varying efficacy, depending on the infecting viral genotype. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2063“…The development of protease inhibitors (PIs) such as telaprevir and boceprevir constitutes a milestone in chronic hepatitis C antiviral treatment since it has achieved sustained virological response (SVR) rates of up to 75% in naïve and 29-88% in treatment-experienced patients with genotype 1 infection. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2064“…Hepatitis C Virus (HCV) encodes two envelope glycoproteins, E1 and E2. …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2065por Tazawa, Junichi, Sakai, Yoshinori, Kusano, Fumihiko, Nagayama, Kazuyoshi, Fujiwara, Hideomi“…Objective: The purpose of this study was to assess the treatment outcome in patients with chronic hepatitis C (CHC) using the current standard antiviral therapy when patient were treated in collaboration between hepatologists and primary care physicians (PCPs). …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2066por Ntagirabiri, Rénovat, Poveda, Jean Dominique, Mumana, Annie, Ndayishimiye, Hermelance“…INTRODUCTION: Hepatitis C virus (HCV) infection is a major public health issue. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2067por De Re, Valli, Caggiari, Laura, De Zorzi, Mariangela, Repetto, Ombretta, Zignego, Anna Linda, Izzo, Francesco, Tornesello, Maria Lina, Buonaguro, Franco Maria, Mangia, Alessandra, Sansonno, Domenico, Racanelli, Vito, De Vita, Salvatore, Pioltelli, Pietro, Vaccher, Emanuela, Beretta, Massimiliano, Mazzaro, Cesare, Libra, Massimo, Gini, Andrea, Zucchetto, Antonella, Cannizzaro, Renato, De Paoli, Paolo“…BACKGROUND: The variability in the association of host innate immune response to Hepatitis C virus (HCV) infection requires ruling out the possible role of host KIR and HLA genotypes in HCV-related disorders: therefore, we therefore explored the relationships between KIR/HLA genotypes and chronic HCV infection (CHC) as they relate to the risk of HCV-related hepatocarcinoma (HCC) or lymphoproliferative disease progression. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2068“…In light of new treatment regimens for hepatitis C, Amitabh Suthar and Anthony Harries outline a wider public health approach for tackling the disease.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2069por Aspinall, Esther Jane, Doyle, Joseph Samuel, Corson, Stephen, Hellard, Margaret Elena, Hunt, David, Goldberg, David, Nguyen, Tim, Falck-Ytter, Yngve, Morgan, Rebecca Lynn, Smith, Bryce, Stoove, Mark, Wiktor, Stefan Zbyszko, Hutchinson, Sharon“…Testing for hepatitis C virus (HCV) infection may reduce the risk of liver-related morbidity, by facilitating earlier access to treatment and care. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2070por Choi, Jung Eun, Kwon, Jung Hyun, Kim, Jung-Hee, Hur, Wonhee, Sung, Pil Soo, Choi, Sang Wook, Yoon, Seung KewEnlace del recurso
Publicado 2015
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2071por Rehan, Harmeet Singh, Chopra, Deepti, Yadav, Madhur, Wardhan, Neeta, Manak, Seema, Siddiqui, KM, Aslam, Mohd.“…OBJECTIVES: To study efficacy and safety of Q-e-I in hepatitis C virus (HCV) infection. METHODS: In this randomized double-blind exploratory study, 60 naive patients of HCV infection were assigned to receive either interferonα2a (IFNα2a) (3 mIU, subcutaneous, thrice weekly), ribavirin (RBV) (1000 mg, orally, twice daily in divided doses) and placebo (n = 30) or IFNα2a, RBV and Q-e-I (5 g, orally, thrice daily in divided doses) (n = 30). …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2072por Conversano, Ciro, Carmassi, Claudia, Carlini, Marina, Casu, Giulia, Gremigni, Paola, Dell’Osso, Liliana“…Health-related quality of life was examined in 49 patients with hepatitis C virus with no psychiatric history who received interferon (IFN)-α treatment. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2073“…Specifically, we will present the “state of play” on viral escape mutations to host T-cell responses in the context of the hepatitis C virus, and their influence on infection outcome.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2074por Black, Antony P., Vilivong, Keooudomphone, Nouanthong, Phonethipsavanh, Souvannaso, Chanthasone, Hübschen, Judith M., Muller, Claude P.“…Sera were tested by ELISA for the presence of antibodies and antigens to hepatitis B, hepatitis C, measles, rubella, varicella zoster, tetanus and diphtheria. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2075por Coretti, Silvia, Romano, Federica, Orlando, Valentina, Codella, Paola, Prete, Sabrina, Di Brino, Eugenio, Ruggeri, Matteo“…BACKGROUND: Hepatitis C is a liver infection caused by hepatitis C virus. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2076
-
2077por Caliskan, Ahmet, Kirisci, Ozlem, Ozkaya, Esra, Ozden, Sevinc, Tumer, Seray, Caglar, Serkan, Guler, Selma Ates, Senol, Hande“…BACKGROUND: The hepatitis C virus (HCV) has six major genotypes and more than 100 subtypes, and the determination of the responsible genotype, collection of epidemiological data, tailoring antiviral therapy, and prediction of prognosis have an important place in disease management. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2078por Bonamassa, Barbara, Ciccarese, Francesco, Antonio, Veronica Di, Contarini, Andrea, Palù, Giorgio, Alvisi, Gualtiero“…Recent studies revealed that the hepatitis C virus (HCV) makes no exception, interacting with the host cell nuclear transport machinery at two different levels. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2079por Chen, Yaqin, Wu, Gang, Zhang, Hongmin, Xu, Hua, Li, Hong, Chen, Ling, Yang, Yixuan, Hu, Peng, Zhang, Dazhi, Ren, Hong, Hu, Huaidong“…Graft reinfection with hepatitis C (HCV) after liver transplantation is a significant problem in transplant hepatology. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2080